Kuros Biosciences AG (SWX:KURN)
Switzerland · Delayed Price · Currency is CHF 22.90
+0.40 (1.78%)
Aug 4, 2026, 12:53 PM CET
Kuros Biosciences AG Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 146.06 | 146.06 | 85.16 | 39.91 | 19.45 | 15.15 |
Revenue Growth | 29.31% | 71.51% | 113.38% | 105.15% | 28.38% | 237.01% |
Gross Profit Gross Profit Growth | 127.45 | 127.45 | 69.92 | 28.46 | 11.65 | 11.04 |
Operating Income Operating Income Growth | 8.95 | 8.95 | -5.63 | -11.44 | -14.54 | -9.62 |
Net Income Net Income Growth | 2.55 | 2.55 | -4.84 | -16.32 | -15.79 | -8.27 |
Earnings Per Share EPS Growth | 0.06 | 0.06 | -0.13 | -0.45 | -0.47 | -0.25 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States of America United States of America Growth | 140.94 | 140.94 | 82.1 | 39 | 18.8 | 14.5 |
European Union European Union Growth | 3.11 | 3.11 | 0.84 | 0.69 | 0.46 | 0.31 |
Other Other Growth | 2.01 | 2.01 | 2.22 | 0.17 | 0.19 | 0.35 |
Total Total Growth | 146.06 | 146.06 | 85.16 | 39.86 | 19.45 | 15.15 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 19.77 | 19.77 | 19.76 | 16.89 | 26.03 | 31.4 |
Total Debt Total Debt Growth | 1.39 | 1.39 | 1.97 | 2.55 | 2.07 | 2.35 |
Net Cash (Debt) Net Cash Growth | 18.38 | 18.38 | 17.8 | 14.35 | 23.96 | 29.04 |
Net Cash Growth | 10.38% | 3.28% | 24.05% | -40.13% | -17.50% | 0.15% |
Net Cash Per Share Net Cash Per Share Growth | 0.44 | 0.44 | 0.48 | 0.39 | 0.71 | 0.89 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -0.46 | -0.46 | 3.54 | -10.52 | -7.95 | -5.99 |
Capital Expenditures CapEx Growth | -2.44 | -2.44 | -1.23 | -0.38 | -0.43 | -0.33 |
Free Cash Flow Free Cash Flow Growth | -2.89 | -2.89 | 2.31 | -10.89 | -8.37 | -6.32 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 87.26% | 87.26% | 82.10% | 71.31% | 59.87% | 72.86% |
Operating Margin | 6.13% | 6.13% | -6.61% | -28.66% | -74.76% | -63.46% |
Pretax Margin | 3.43% | 3.43% | -4.43% | -29.13% | -88.91% | -69.16% |
Profit Margin | 1.69% | 1.69% | -4.92% | -30.26% | -81.15% | -54.59% |
FCF Margin | -1.98% | -1.98% | 2.71% | -27.29% | -43.04% | -41.72% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 438.90 | 578.36 | - | - | - | - |
Forward PE | 101.35 | 80.23 | - | - | - | - |
P/FCF Ratio | - | - | 388.14 | - | - | - |
PS Ratio | 7.67 | 9.30 | 10.51 | 3.82 | 2.99 | 4.56 |